Session » (0965–0992) Epidemiology & Public Health Poster II
- 9:00AM-11:00AM
-
Abstract Number: 0985
Assessing the Value of Comorbidity Clusters in Predicting Clinical Outcomes in Rheumatoid Arthritis: A Machine Learning Approach Using a Very Large US Registry
- 9:00AM-11:00AM
-
Abstract Number: 0983
Association Between Disease-modifying Anti-rheumatic Drugs and Short-term Outcomes of Dengue: A Population-based, Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 0992
Association Between Metabolic Syndrome and the Presence of Enthesophytes on Musculoskeletal Ultrasound Compared to Joint X-ray
- 9:00AM-11:00AM
-
Abstract Number: 0975
Association of HLA-DRB1 Alleles with Ischemic Events and Mortality in a Multi-ethnic Community-living Population
- 9:00AM-11:00AM
-
Abstract Number: 0990
Association of Treatment and Disease Activity with Antibiotic Use and Hospitalized Infection Among People Living with Rheumatoid Arthritis: Baseline Data from a Longitudinal Study in the ArthritisPower Registry
- 9:00AM-11:00AM
-
Abstract Number: 0965
Comparing Predictors of DAPSA28, DAPSA66/68 and DAS28-CRP Remission at 6 Months in Bio-naive Patients with Psoriatic Arthritis Initiating a TNFi in Clinical Practice – Results from the EuroSpA Collaboration
- 9:00AM-11:00AM
-
Abstract Number: 0970
Comparison of Survival on Treatment and Severe Infection Among New Users of Biosimilar vs. Originator Biologics in Inflammatory Arthritis: Population-based Evidence from a Natural Experiment Due to a Policy Change
- 9:00AM-11:00AM
-
Abstract Number: 0988
Elderly Patients’ Discontinuation of Biologic DMARDs in Patients with Rheumatic Diseases: Data from the Mexican Adverse Events Registry (BIOBADAMEX)
- 9:00AM-11:00AM
-
Abstract Number: 0984
Factors Associated with 5-year Mortality in Patients with Rheumatoid Arthritis Initiating Their First Biological or Target Synthetic DMARDs: A Nationwide, Population-based Cohort Study of 12,612 Patients
- 9:00AM-11:00AM
-
Abstract Number: 0978
Identifying Important Clinical Features for Predicting Remission in Patients with Rheumatoid Arthritis Treated with Biologics Using Machine Learning Model
- 9:00AM-11:00AM
-
Abstract Number: 0972
Increased Incidence of Inflammatory Arthritis After COVID-19 in a Colombian Population
- 9:00AM-11:00AM
-
Abstract Number: 0986
Medication Use Patterns and Factors Associated with Abnormal Pregnancy Outcomes in Patients with Rheumatoid Arthritis in Korea
- 9:00AM-11:00AM
-
Abstract Number: 0971
Network Meta Analyses of the Effectiveness and Safety Profiles of Janus Kinase Inhibitors and Biologic Agents in Treating Children with Non-systemic Juvenile Idiopathic Arthritis (nsJIA)
- 9:00AM-11:00AM
-
Abstract Number: 0967
Overall Survival in Patients with versus Without Rheumatoid Arthritis Initiating Immune Checkpoint Inhibitors for Metastatic Non Small Cell Lung Cancer
- 9:00AM-11:00AM
-
Abstract Number: 0977
Prevalence of Arthritis in the United States: National Estimates from a Population-based Study
- 9:00AM-11:00AM
-
Abstract Number: 0973
Real-World Comparative Effectiveness Study of Janus Kinase Inhibitors Compared to Biologic Disease Modifying Antirheumatic Drugs in Korean Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 0989
Rheumatoid Arthritis and Risk of Migraine: A Population-based Nationally Representative Cohort
- 9:00AM-11:00AM
-
Abstract Number: 0987
Risk Factors and Predictors of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis: Data from the Mexican Adverse Events Registry (BIOBADAMEX)
- 9:00AM-11:00AM
-
Abstract Number: 0968
Risk of Incident Heart Failure and Heart Failure Subtypes in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 0976
Sarcopenia and All-Cause Mortality in US Adults with and Without Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 0982
Systemic Autoimmune Rheumatic Diseases (SARD) in the Agricultural Health Study Cohort: Rates of Rheumatoid Arthritis (RA) and Other SARD Among Medicare-linked Participants
- 9:00AM-11:00AM
-
Abstract Number: 0980
Temporal Trends in Incidence Rates of Seropositive and Seronegative Rheumatoid Arthritis: A Danish Nationwide Population-based Study
- 9:00AM-11:00AM
-
Abstract Number: 0966
The Burden of Oligoarticular Psoriatic Arthritis in the United States
- 9:00AM-11:00AM
-
Abstract Number: 0981
Time Trends in Overall Infection Risk in Patients with Inflammatory Arthritides Treated with Tumor Necrosis Factor Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 0991
Trends in Arthroplasty Utilization for Inflammatory Arthritis Including Rheumatoid Arthritis and Spondyloarthritis in China: Analysis of a Large National Database
- 9:00AM-11:00AM
-
Abstract Number: 0969
Tumor Necrosis Factor-α Inhibitors Reduces Obstructive Sleep Apnea in Patients with Juvenile Idiopathic Arthritis: A Population-based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 0979
Use and Discontinuation of Tumour Necrosis Factor Inhibitors Among Pregnant Women with Chronic Inflammatory Diseases